Please use this identifier to cite or link to this item:
http://cmuir.cmu.ac.th/jspui/handle/6653943832/50570
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Jiradej Manosroi | en_US |
dc.contributor.author | Kanjana Rueanto | en_US |
dc.contributor.author | Korawinwich Boonpisuttinant | en_US |
dc.contributor.author | Worapaka Manosroi | en_US |
dc.contributor.author | Christophe Biot | en_US |
dc.contributor.author | Hiroyuki Akazawa | en_US |
dc.contributor.author | Toshihiro Akihisa | en_US |
dc.contributor.author | Witchapong Issarangporn | en_US |
dc.contributor.author | Aranya Manosroi | en_US |
dc.date.accessioned | 2018-09-04T04:42:29Z | - |
dc.date.available | 2018-09-04T04:42:29Z | - |
dc.date.issued | 2010-05-27 | en_US |
dc.identifier.issn | 15204804 | en_US |
dc.identifier.issn | 00222623 | en_US |
dc.identifier.other | 2-s2.0-77952734111 | en_US |
dc.identifier.other | 10.1021/jm901866m | en_US |
dc.identifier.uri | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=77952734111&origin=inward | en_US |
dc.identifier.uri | http://cmuir.cmu.ac.th/jspui/handle/6653943832/50570 | - |
dc.description.abstract | Seven novel ferrocenic derivatives, compounds 1-7, were synthesized from steroidal drugs by Aldol condensation reaction. The derivatives were purified by chromatography, and their structures were determined on the basis of HR-ESI-MS and two-dimensional NMR spectroscopy. The purity of all derivatives was more than 95%. Compounds 1-5 demonstrated anti-proliferative activity on HeLa cell line by SRB assay more than their parent compounds. All seven derivatives showed anti-oxidative activities evaluated by DPPH scavenging and metal ion chelating, while their parent compounds gave no activity. Compound 1 indicated the most potent anti-proliferative activity similar to doxorubicin, with the GI 50 at 0.223 ± 0.014 μg/mL. Compounds 6 and 7 demonstrated similar potent in vivo anti-inflammatory to their parent compounds (prednisolone and hydrocortisone) at 80.99 ± 13.5 and 68.24 ± 10.4% edema inhibition, respectively. This study has suggested that the novel compound 1 was the most potential derivative that can be further developed for cancer treatment. © 2010 American Chemical Society. | en_US |
dc.subject | Biochemistry, Genetics and Molecular Biology | en_US |
dc.subject | Pharmacology, Toxicology and Pharmaceutics | en_US |
dc.title | Novel ferrocenic steroidal drug derivatives and their bioactivities | en_US |
dc.type | Journal | en_US |
article.title.sourcetitle | Journal of Medicinal Chemistry | en_US |
article.volume | 53 | en_US |
article.stream.affiliations | Chiang Mai University | en_US |
article.stream.affiliations | Universite des Sciences et Technologies de Lille | en_US |
article.stream.affiliations | Nihon University | en_US |
Appears in Collections: | CMUL: Journal Articles |
Files in This Item:
There are no files associated with this item.
Items in CMUIR are protected by copyright, with all rights reserved, unless otherwise indicated.